Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Tyra Biosciences, Inc. (TYRA) Institutional Ownership & Insider Trading

170 institutions reported holding Tyra Biosciences, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 15 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

TYRATyra Biosciences, Inc.Follow TYRA — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
1.2B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
3 Nov, in 10 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

170 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +10.8%.

Increased+72New+29Decreased-41Closed-21

Largest moves, shares (millions)

T. Rowe Price Associates+1.8MFMR+1.2MHood River Capital…+1.0MLogos Global Management-0.8MBarclays-0.8MCommodore Capital-0.6M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+0.1Sep 24+1.4Dec 24+7.0Mar 25+3.0Jun 25-0.9Sep 25+0.0Dec 25+8.9Mar 26+6.3Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2617069+10.8%72294121
Mar 2616466+16.1%58383212
Dec 2513357+0.1%4223369
Sep 2511556-1.6%3873513
Jun 2512157+5.5%59161912
Mar 2511754+16.4%40192514
Dec 2411249+3.3%32262514
Sep 249547+0.1%2521208

Tyra Biosciences, Inc. — questions

Who owns Tyra Biosciences, Inc. stock?
170 institutions reported Tyra Biosciences, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: RA CAPITAL MANAGEMENT, L.P. (20.4%), FMR LLC (14.9%), Jupiter Topco LLC (7.3%).
Are Tyra Biosciences, Inc. insiders buying or selling?
15 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Tyra Biosciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.